Patricia Ann Delgrosso, RN, RNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 12 Boyd Ln, Randolph, NJ 07869 Phone: 973-361-4621 |
Marilyn Soberano Iv, HEMODIALYSIS RN. Registered Nurse - Hemodialysis Medicare: Not Enrolled in Medicare Practice Location: 2105 Barclay Ct, Randolph, NJ 07869 Phone: 973-978-7351 Fax: 973-927-1873 |
Fengyu Jiang, RNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 21 Rolling Ridge Rd, Randolph, NJ 07869 Phone: 973-876-7187 |
Mrs. Nancy Enid Mejias-cepeda, RN Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 4 Nuko Ter, Randolph, NJ 07869 Phone: 973-895-9952 |
Elizabeth Cornock, RN, AGNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 37 Everdale Rd, Randolph, NJ 07869 Phone: 201-230-0093 |
Mrs. Michelle M Bartlett, RN, MSN, FNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 765 Route 10 E Ste 203, Randolph, NJ 07869 Phone: 973-659-9991 |
Ms. Renita Barbara Holtz, RNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 10 Oak Ln, Randolph, NJ 07869 Phone: 973-361-2729 Fax: 973-361-3478 |
Lisa Barmore, Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 7 Trowbridge Dr, Randolph, NJ 07869 Phone: 917-653-5103 |
Dannette Arboleda-marin, RNFA Registered Nurse - Registered Nurse First Assistant Medicare: Medicare Enrolled Practice Location: 447 Route 10 E Ste 15, Randolph, NJ 07869 Phone: 973-442-3016 Fax: 973-442-3017 |
News Archive
A study of 992 patients with stage III colon cancer found that those who reported a healthy lifestyle during and following adjuvant (post-surgery) treatment had a 42% lower chance of death and a trend for lower chance of cancer recurrence than those who had less healthy lifestyles.
Conventional wisdom holds that when the risk of catching a disease is high, people are more likely to get vaccinated to protect themselves.
NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).
A mere 25 years ago, noncoding RNAs were considered nothing more than "background noise" in the overall genomic landscape. Now, two new studies reveal that one of these tiny noncoding molecules - microRNA-22 - plays an outsized role in two types of cancer.
› Verified 8 days ago